In addition, hypertrophic markers such as ANP and BNP, and the cardiac fibrotic marker MMP9 were also substantially increased in TAC-challenged hypertrophic hearts compared with sham group, suggesting that TAC-induced myocardial hypertrophy model was successfully constructed (Fig. 2a). The gene discussed is NPPB; the disease is cardiac hypertrophy.